- Home
- KROS vs NMG Comparison
KROS vs NMG Comparison
Compare KROS & NMG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KROS
- NMG
- Stock Information
- Founded
- KROS 2015
- NMG 2011
- Country
- KROS United States
- NMG Canada
- Employees
- KROS N/A
- NMG N/A
- Industry
- KROS Biotechnology: Pharmaceutical Preparations
- NMG Other Metals and Minerals
- Sector
- KROS Health Care
- NMG Basic Materials
- Exchange
- KROS Nasdaq
- NMG Nasdaq
- Market Cap
- KROS 565.0M
- NMG 534.9M
- IPO Year
- KROS 2020
- NMG 2017
- Fundamental
- Price
- KROS $15.91
- NMG $5.09
- Analyst Decision
- KROS Buy
- NMG Strong Buy
- Analyst Count
- KROS 14
- NMG 2
- Target Price
- KROS $20.56
- NMG $2.58
- AVG Volume (30 Days)
- KROS 424.2K
- NMG 777.3K
- Earning Date
- KROS 11-05-2025
- NMG 11-13-2025
- Dividend Yield
- KROS N/A
- NMG N/A
- EPS Growth
- KROS N/A
- NMG N/A
- EPS
- KROS 0.47
- NMG N/A
- Revenue
- KROS $232,844,000.00
- NMG N/A
- Revenue This Year
- KROS $6,657.47
- NMG N/A
- Revenue Next Year
- KROS N/A
- NMG N/A
- P/E Ratio
- KROS $34.14
- NMG N/A
- Revenue Growth
- KROS 85820.30
- NMG N/A
- 52 Week Low
- KROS $9.12
- NMG $1.22
- 52 Week High
- KROS $72.37
- NMG $5.75
- Technical
- Relative Strength Index (RSI)
- KROS 54.08
- NMG 86.16
- Support Level
- KROS $15.50
- NMG $3.14
- Resistance Level
- KROS $16.44
- NMG $4.10
- Average True Range (ATR)
- KROS 0.57
- NMG 0.47
- MACD
- KROS -0.01
- NMG 0.18
- Stochastic Oscillator
- KROS 59.87
- NMG 81.22
About KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.
About NMG Nouveau Monde Graphite Inc.
Nouveau Monde Graphite Inc is a mineral exploration company. The company specializes in the exploration, evaluation, and development of mineral properties located in Quebec and is developing a natural graphite-based anode material that would qualify as battery-grade material to supply the lithium-ion industry. The company currently operates in two segments: the Matawinie Mine Project and the Battery Material Plant project.